The MENA syringes and cannulas market is set for remarkable growth, with sales expected to reach USD 2,824.7 million by 2034, up from an estimated USD 1,592.2 million in 2024. The market is projected to grow at a compound annual growth rate (CAGR) of 5.9% over the forecast period from 2024 to 2034, highlighting a robust demand for these critical healthcare devices.
In 2023, the revenue from syringes alone amounted to USD 1,108.1 million, reflecting the significant role these devices play in medical treatments. The industry is anticipated to experience a year-over-year growth of 5.9% in 2024, underlining the sustained and increasing need for syringes and cannulas in the region.
Syringes are expected to continue dominating the MENA market, commanding over 73.7% of the market share. This strong performance is driven by the rising prevalence of chronic diseases such as diabetes and cancer, which necessitate regular injections. Additionally, the growing adoption of injectable drugs for various medical conditions contributes to the segment’s expansion.
Several factors are fueling the market’s growth, including rapid urbanization, increased healthcare spending across the MENA region, and the rising adoption of advanced syringes and cannulas featuring enhanced safety features. These developments are pivotal in meeting the region’s healthcare needs and ensuring better patient outcomes.
“We are witnessing a significant shift in the healthcare landscape in MENA, with a marked increase in the demand for syringes and cannulas,” said FMI. “The growth is driven by various factors including the rising incidence of chronic diseases, improved healthcare infrastructure, and the advancement of medical technologies. We are committed to meeting this demand and contributing to the region’s health and wellbeing.”
Key Takeaways: Syringes & Cannula Market in MENA
- The MENA syringes & cannula market is projected to grow steadily, with a CAGR of 5.9% from 2024 to 2034.
- Sales are expected to increase from USD 1.59 billion in 2024 to USD 2.82 billion by 2034.
- The market experienced a CAGR of 4.7% during the historical period (2019-2023).
- Sales increased from USD 1.18 billion in 2019 to USD 1.50 billion in 2023.
- Saudi Arabia Holds the largest market share (15.8%) and is expected to maintain its position.
- Turkey Also holds a significant market share (12.4%) and is projected to grow at a steady pace.
- UAE, Egypt, Morocco, Qatar, and Kuwait: These countries are expected to experience strong growth rates during the forecast period.
Access the Newest Reports from Get Old Source
Competitive Landscape:
Key players in the syringes and cannula market are focusing on expanding their geographical reach by enhancing their direct sales channels and distributor networks. They are also pursuing strategic collaborations to launch new products.
Recent Developments in the MENA Syringes and Cannula Market:
In November 2021, Diabeloop SA, a leader in therapeutic AI, partnered with Terumo Corporation to develop Automated Insulin Delivery (AID) solutions for Japan and Europe, with plans to extend their offerings to the MENA region.
In the same month, Becton Dickinson & Company increased their manufacturing capacity in Spain to bolster their presence in Europe and strengthen their distribution network in the MENA region.
Key Players:
- Ambu A/S
- Becton, Dickinson, and Company
- Cardinal Health
- B. Braun Medical Inc.
- Medline Industries Inc.
- Nipro Corporation
- Terumo Corporation
- Hindustan Syringes & Medical Devices Ltd.
- Schott Kaisha Private Limited
- Edwards Lifesciences Corporation
- Abu Dhabi National Industrial Projects Company
- Middle East Medical
- Medtronic Plc.
- The 3M Company
- Honeywell International Inc.
- Kimberly-Clark Corporation
- DuPont de Nemours, Inc.
- Top Glove Corporation Bhd
- Ansell Limited
- Hartalega Holdings Berhad
Key Segments of Reconditioned IBC Industry
By Product:
In terms of product, the industry is divided into syringes (disposable hypodermic syringes, auto disposable syringes, safety syringes, prefilled syringes, insulin syringes), and cannula (neonatal cannula, straight cannula, winged cannula, cannula with wings & port, cannula with integrated stop cock, nasal cannula)
By Usage:
In terms of usage, the industry is segregated into reusable and disposable.
By Distribution Channel:
The industry is classified distribution channel as institutional sales (hospitals, ambulatory surgical centres, office-based clinics, skilled nursing facilities & long term care centres, diagnostic laboratories and academic and research institutions), retail sales (retail pharmacies, drug stores, retail stores {hypermarket/supermarket}, online sales)
By Region:
Key countries of MENA, including Algeria, Iran, Israel, Egypt, UAE, Saudi Arabia, Morocco, Kuwait, Qatar, Turkey, and Rest of MENA have been covered in the report.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
